Glucose tolerance in gestational diabetic women during and after treatment with a combination-type oral contraceptive.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D050260:Carbohydrate Metabolism; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000175:diagnosis / Q000378:metabolism; D005260:Female; D005865:Gestational Age; D005951:Glucose Tolerance Test; D006801:Humans; D008656:Mestranol / Q000009:adverse effects*; D009640:Norethindrone / Q000009:adverse effects*; D011236:Prediabetic State / Q000175:diagnosis; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000175:diagnosis
D001786:Blood Glucose; D003276:Contraceptives, Oral; D008656:Mestranol; D009640:Norethindrone